Increasing the Detection and Response to Adherence Problems with Cardiovascular Medication in Primary Care through Computerized Drug Management Systems: A Randomized Controlled Trial

Abstract

Background. Adherence with antihypertensive and lipid-lowering therapy is poor, resulting in an almost 2-fold increase in hospitalization. Treatment side effects, cost, and complexity are common reasons for nonadherence, and physicians are often unaware of these potentially modifiable problems. Objective. To determine if a cardiovascular medication tracking and nonadherence alert system, incorporated into a computerized health record system, would increase drug profile review by primary care physicians, increase the likelihood of therapy change, and improve adherence with antihypertensive and lipid-lowering drugs. Methods. There were 2293 primary care patients prescribed lipid-lowering or antihypertensive drugs who were randomized to the adherence tracking and alert system or active medication list alone to determine if the intervention increased drug profile review, changes in cardiovascular drug treatment, and refill adherence in the first 6 months. An intention to treat analysis was conducted using generalized estimating equations to account for clustering within physician. Results. Overall, medication adherence was below 80% for 36.3% of patients using lipid-lowering drugs and 40.8% of patients using antihypertensives at the start of the trial. There was a significant increase in drug profile review in the intervention compared to the control group (44.5% v. 35.5%; P < 0.001), a nonsignificant increase in drug discontinuations due to side effects (2.3% v. 2.0%; P = 0.61), and a reduction in therapy increases (28.5% v. 29.1%; P = 0.86). There was no significant change in refill adherence after 6 months of follow-up. Conclusion. An adherence tracking and alert system increases drug review but not therapy changes or adherence in prevalent users of cardiovascular drug treatment. Targeting incident users where adverse treatment effects are more common and combining adherence tracking and alert tools with motivational interventions provided by multidisciplinary primary care teams may improve the effectiveness of the intervention.

Keywords

medication adherence computer decision support cardiovascular RCT.

References

Daar AS , Singer PA , Persad DL , et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450(7169): 494-6.

Ford ES , Ajani UA , Croft JB , et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-98.

Simpson SH , Eurich DT , Majumdar SR , et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J. 2006;333(7557):15.

Rasmussen JN , Chong A. , Alter DA Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction . JAMA. 2007;297(2): 177-86.

Avorn J. , Monette J. , Lacour A. , et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998; 279(18):1458-62.

Jackevicius CA , Mamdani M. , Tu JV Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462-7.

Grant RW , O'Leary KM , Weilburg JB , Singer DE , Meigs JB Impact of concurrent medication use on statin adherence and refill persistence . Arch Intern Med. 2004;164(21):2343-8.

Caro JJ , Speckman JL , Salas M. , Raggio G. , Jackson JD Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J. 1999; 160(1):41-6.

Perreault S. , Lamarre D. , Blais L. , et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother. 2005;39(9):1401-8.

10.

Hughes DA , Bagust A. , Haycox A. , Walley T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ. 2001 ;10(7):601-15.

11.

Chou CC , Lee MS , Ke CH , Chuang MH Factors influencing the switch in the use of antihypertensive medications . Int J Clin Pract. 2005;59(1):85-91.

12.

Mazzaglia G. , Mantovani LG , Sturkenboom MC , et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005;23(11):2093-100.

13.

Hughes D. , McGuire A. The direct costs to the NHS of discontinuing and switching prescriptions for hypertension. J Hum Hypertens. 1998;12(8):533-7.

14.

Martin RM , Kerry SM , Hilton SR Initial treatment choices, second-line therapy, and reasons for stopping medication in the treatment of hypertension by general practitioners in England, Scotland and Wales: 1990-1995. Pharmacoepidemiol Drug Saf. 1997;6(4):253-61.

15.

Wang PS , Benner JS , Glynn RJ , Winkelmayer WC , Mogun H. , Avorn J. How well do patients report noncompliance with antihypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004;13(1): 11-19.

16.

Gregoire JP , Moisan J. , Guibert R. , et al. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol . 2002;55(7):728-35.

17.

Lowry KP , Dudley TK , Oddone EZ , Bosworth HB Intentional and unintentional nonadherence to antihypertensive medication . Ann Pharmacother. 2005;39(7-8):1198-203.

18.

Gandhi TK , Weingart SN , Borus J. , et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64.

19.

Kjellgren KI , Svensson S. , Ahlner J. , Saljo R. Antihypertensive medication in clinical encounters . Int J Cardiol. 1998;64(2):161-9. 20. Canada Health Infoway Inc. Presentation of business plan, 2007. Available from: URL: www.canadahealthinfoway.ca

20.

Sikka R. , Xia F. , Aubert RE Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7): 449-57.

21.

Hess LM , Raebel MA , Conner DA , Malone DC Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother . 2006;40(7-8):1280-8.

22.

Steiner JF , Prochazka AV The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-16.

23.

Tamblyn R. , Huang A. , Kawasumi Y. , et al. The development and evaluation of an integrated electronic prescribing and drug managment system for primary care. J Am Med Inform Assoc. 2006;13(2):148-59.

24.

Tamblyn R. , Laprise R. , Hanley JA , et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001 ;285(4):421-9.

25.

Eguale T. , Tamblyn R. , Winslade N. , Buckeridge DL Detection of adverse drug events and other treatment outcomes using an electronic prescribing system. Drug Safety. 2008;31(11):1005-16.

26.

Kawasumi Y. , Tamblyn R. , Platt R. , Ernst P. , Abrahamowicz M. , Taylor L. Evaluation of the use of an integrated drug information system by primary care physicians for vulnerable population. Int J Med Inform. In press.

27.

Vik SA , Maxwell CJ , Hogan DB Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303-12.

28.

IMS Canada. Data provided by IMS Canada. Kirkland, Canada: IMS Canada; 2006.

29.

Bourgault C. , Senecal M. , Brisson M. , Marentette MA , Gregoire JP Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens. 2005;19(8):607-13.

30.

Kjellgren KI , Svensson S. , Ahlner J. , Saljo R. Antihypertensive treatment and patient autonomy: the follow-up appointment as a resource for care. Patient Educ Couns. 2000;40(1): 39-49.

31.

Kjellgren KI , Ahlner J. , Dahlof B. , Gill H. , Hedner T. , Saljo R. Perceived symptoms amongst hypertensive patients in routine clinical practice: a population-based study. J Intern Med. 1998; 244(4):325-32.

32.

Phatak HM , Thomas J. III. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006 ;40(10):1737-42.

33.

Sittig DF , Krall MA , Dykstra RH , Russell A. , Chin HL A survey of factors affecting clinician acceptance of clinical decision support . BMC Med Inform Decis Mak. 2006;6:6.

34.

Schroeder K. , Fahey T. , Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722-32.

35.

McDonald HP , Garg AX , Haynes RB Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-79.

36.

Roter DL , Hall JA , Merisca R. , Nordstrom B. , Cretin D. , Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis . Med Care. 1998;36(8):1138-61.

37.

Harmon G. , Lefante J. , Krousel-Wood M. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol. 2006;21(4):310-5.

38.

Krousel-Wood M. , Hyre A. , Muntner P. , Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005;20(4):296-300.

39.

Lee JK , Grace KA , Taylor AJ Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71.